<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:media="http://search.yahoo.com/mrss/"><channel><title>Zibb.com: Lilly, Eli, &amp; Co (Industry News &amp; Blogs)</title><link>http://www.zibb.com/all/theme/cq/Lilly,+Eli,+&amp;+Co</link><atom:link rel="self" type="application/rss+xml" href="http://www.zibb.com/all/theme/cq/Lilly,+Eli,+&amp;+Co" /><description>
					Zibb. The Global business search engine.
				</description><language>
					en-US
				</language><webMaster>search@zibb.com (RB Search)</webMaster><copyright>Copyright (c) 2007 Reed Business Information. All rights reserved.</copyright><pubDate>Wed, 25 Nov 2009 13:36:16 GMT</pubDate><lastBuildDate>Wed, 25 Nov 2009 13:36:16 GMT</lastBuildDate><ttl>60</ttl><image><title>Zibb.com: Lilly, Eli, &amp; Co (Industry News &amp; Blogs)
          </title><width>88</width><height>31</height><link>http://www.zibb.com/all/theme/cq/Lilly,+Eli,+&amp;+Co</link><url>
						http://www.zibb.com/images/en/g_zibb_logo_beta.gif
					</url></image><item><title>Eli Lilly Up 6.3% Since SmarTrend's Buy Recommendation - Zibb.com</title><link>http://www.zibb.com/article/5693376/Eli+Lilly+Up+Since+SmarTrend+s+Buy+Recommendation</link><description>SmarTrend, our proprietary pattern recognition system, called an Uptrend for Eli Lilly (NYSE:LLY) on October 20, 2009 at $35.24. Since then, Eli Lilly has returned 6.3% as of today's recent price of $37.45. Want to profit from these alerts? Go to www.mysmartrend.com now for a FREE two-week trial.</description><guid>http://www.zibb.com/article/5693376/Eli+Lilly+Up+Since+SmarTrend+s+Buy+Recommendation</guid><category domain="http://www.zibb.com">Lilly, Eli, &amp; Co</category><pubDate>Wed, 25 Nov 2009 13:36:16 GMT</pubDate><source url="http://www.zibb.com" /></item><item><title>PRIMECAP Management Top Purchases: Amgen Inc., The Boeing Company...
      </title><link>http://www.gurufocus.com/news.php?id=77020</link><description>GuruFocus tracks the stock buys, sells and commentaries of stock investment gurus such as Warren Buffett, George Soros, the best investors.</description><guid>http://www.gurufocus.com/news.php?id=77020</guid><category domain="http://www.zibb.com">Lilly, Eli, &amp; Co</category><pubDate>Sun, 22 Nov 2009 15:43:34 GMT</pubDate><source url="http://www.gurufocus.com" /></item><item><title>Update: Utah Settles with Eli Lilly in Zyprexa Case</title><link>http://commonlaw.findlaw.com/2009/11/update-utah-settles-with-eli-lilly-in-zyprexa-case.html</link><description>As we previously discussed regarding Eli Lilly's $1.42 Billion Zyprexa settlement, major pharmaceutical company Eli Lilly has faced a host of suits over its marketing tactics for the drug Zyprexa.</description><guid>http://commonlaw.findlaw.com/2009/11/update-utah-settles-with-eli-lilly-in-zyprexa-case.html</guid><category domain="http://www.zibb.com">Lilly, Eli, &amp; Co</category><pubDate>Tue, 17 Nov 2009 19:39:34 GMT</pubDate><source url="http://commonlaw.findlaw.com" /></item><item><title>Dr. Steven M. Paul to Retire from Lilly as Executive Vice Preside...
      </title><link>http://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=10678</link><description>Dr. Steven M. Paul to Retire from Lilly as Executive Vice President, Science and Technology, President, Lilly Research Laboratories; Dr. Jan M. Lundberg, Executive Vice President, Head of Global Discovery Research, AstraZeneca, Named his SuccessorPR</description><guid>http://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=10678</guid><category domain="http://www.zibb.com">Lilly, Eli, &amp; Co</category><pubDate>Mon, 16 Nov 2009 01:00:00 GMT</pubDate><source url="http://www.pharmiweb.com" /></item><item><title>Effient(R) Exhibited Greater Antiplatelet Activity than High Dose...
      </title><link>http://finance.yahoo.com/news/EffientR-Exhibited-Greater-prnews-2405209527.html?x=0&amp;.v=1</link><description>ORLANDO, Fla., Nov. 15 /PRNewswire-FirstCall/ -- Results from a new study showed patients with type 2 diabetes mellitus who also had coronary artery disease (CAD) and</description><guid>http://finance.yahoo.com/news/EffientR-Exhibited-Greater-prnews-2405209527.html?x=0&amp;.v=1</guid><category domain="http://www.zibb.com">Lilly, Eli, &amp; Co</category><pubDate>Sun, 15 Nov 2009 20:00:00 GMT</pubDate><source url="http://finance.yahoo.com" /></item><item><title>Eli Lilly Adds New Head of Research - FOXBusiness.com</title><link>http://www.foxbusiness.com/story/markets/industries/health-care/eli-lilly-adds-new-head-research/?utm_source=feedburner&amp;utm_medium=feed&amp;utm_campaign=Feed%3A+foxbusiness%2Flatest+%28FOXBusiness.com+-+Latest+News%29</link><description>Eli Lilly and Co. (LLY) has poached Jan Lundberg, AstraZeneca Plc’s head of drug discovery, to be its new head of research.</description><guid>http://www.foxbusiness.com/story/markets/industries/health-care/eli-lilly-adds-new-head-research/?utm_source=feedburner&amp;utm_medium=feed&amp;utm_campaign=Feed%3A+foxbusiness%2Flatest+%28FOXBusiness.com+-+Latest+News%29</guid><category domain="http://www.zibb.com">Lilly, Eli, &amp; Co</category><pubDate>Fri, 13 Nov 2009 21:30:11 GMT</pubDate><source url="http://www.foxbusiness.com" /></item><item><title>Eli Lilly Head of Research, Development to Retire</title><link>http://abcnews.go.com/Business/wireStory?id=9075017</link><description>Indianapolis-based Lilly said Steven Paul will retire on Feb. 28, 2010. Paul, 59, is in charge of science and technology and president of Lilly Research Laboratories. He will be replaced by Jan Lundberg, head of global discovery research for AstraZeneca.</description><guid>http://abcnews.go.com/Business/wireStory?id=9075017</guid><category domain="http://www.zibb.com">Lilly, Eli, &amp; Co</category><pubDate>Fri, 13 Nov 2009 16:13:18 GMT</pubDate><source url="http://abcnews.go.com" /></item><item><title>Eli Lilly head of research, development to retire</title><link>http://www.newsvine.com/_news/2009/11/13/3497929-eli-lilly-head-of-research-development-to-retire</link><description>Eli Lilly &amp; Co. said Friday its science and technology head will retire. The drugmaker hired the chief researcher at AstraZeneca PLC to replace him.</description><guid>http://www.newsvine.com/_news/2009/11/13/3497929-eli-lilly-head-of-research-development-to-retire</guid><category domain="http://www.zibb.com">Lilly, Eli, &amp; Co</category><pubDate>Fri, 13 Nov 2009 15:39:43 GMT</pubDate><source url="http://www.newsvine.com" /></item><item><title>Fitch cuts its outlook on Eli Lilly to negative (at MarketWatch)</title><link>http://www.marketwatch.com/story/fitch-cuts-its-outlook-on-eli-lilly-to-negative-2009-11-13?siteid=yhoof2</link><description>NEW YORK (MarketWatch) -- Fitch Ratings has changed its rating outlook Friday on Eli Lilly &amp; Co. to negative from stable, which applies to about $6.77 billion of outstanding debt. Fitch said the move reflects its</description><guid>http://www.marketwatch.com/story/fitch-cuts-its-outlook-on-eli-lilly-to-negative-2009-11-13?siteid=yhoof2</guid><category domain="http://www.zibb.com">Lilly, Eli, &amp; Co</category><pubDate>Fri, 13 Nov 2009 15:15:30 GMT</pubDate><source url="http://www.marketwatch.com" /></item><item><title>Lilly Research Labs president set to retire in 2010</title><link>http://www.drugstorenews.com/story.aspx?id=122787&amp;utm_source=feedburner&amp;utm_medium=feed&amp;utm_campaign=Feed%3A+DSNRssChannel+%28Drug+Store+News+RSS+channel%29</link><description>A top executive of Eli Lilly &amp; Co. plans to retire, the drug maker announced Friday.</description><guid>http://www.drugstorenews.com/story.aspx?id=122787&amp;utm_source=feedburner&amp;utm_medium=feed&amp;utm_campaign=Feed%3A+DSNRssChannel+%28Drug+Store+News+RSS+channel%29</guid><category domain="http://www.zibb.com">Lilly, Eli, &amp; Co</category><pubDate>Fri, 13 Nov 2009 12:00:00 GMT</pubDate><source url="http://www.drugstorenews.com" /></item><item><title>Eli Lilly Units Pumping Up Drug Pipeline</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3607049&amp;HITNO=11&amp;MSIZE=1000&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=biotechnology%20pharmaceutical&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R%3adate&amp;R=3607049&amp;THISHREF=http%3a//c.moreover.com/click/here.pl%3fz2322136014%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><description>Biotechnology and Pharmaceutical Industry Search Find Companies, News, Events, Jobs, Directory</description><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3607049&amp;HITNO=11&amp;MSIZE=1000&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=biotechnology%20pharmaceutical&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R%3adate&amp;R=3607049&amp;THISHREF=http%3a//c.moreover.com/click/here.pl%3fz2322136014%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><category domain="http://www.zibb.com">Lilly, Eli, &amp; Co</category><pubDate>Tue, 10 Nov 2009 08:13:41 GMT</pubDate><source url="http://www.bioportfolio.co.uk" /></item><item><title>VIDEO from Medialink and Eli Lilly and Company: Award-winning Dia...
      </title><link>http://www.prnewswire.com/news-releases/video-from-medialink-and-eli-lilly-and-company-award-winning-diabetes-documentary-to-make-world-tv-premiere-on-sundance-channel-on-world-diabetes-day-68569437.html</link><description>VIDEO from Medialink and Eli Lilly and Company: Award-winning Diabetes Documentary to Make World TV Premiere on Sundance Channel on World Diabetes Day. Life for a Child film debuted at Tribeca festival, named Best Documentary Short at Cinequest.</description><guid>http://www.prnewswire.com/news-releases/video-from-medialink-and-eli-lilly-and-company-award-winning-diabetes-documentary-to-make-world-tv-premiere-on-sundance-channel-on-world-diabetes-day-68569437.html</guid><category domain="http://www.zibb.com">Lilly, Eli, &amp; Co</category><pubDate>Mon, 02 Nov 2009 16:03:00 GMT</pubDate><source url="http://www.prnewswire.com" /></item><item><title>Makarem  Associates Files Wrongful Death Lawsuit Against Eli Lill...
      </title><link>http://www.prlog.org/10395248-makarem-associates-files-wrongful-death-lawsuit-against-eli-lilly-for-its-drug-zyprexa.html</link><description>Makarem &amp; Associates Files Wrongful Death Lawsuit Against Eli Lilly For Its Drug Zyprexa. Makarem &amp; Associates files lawsuit charging drug manufacturer Eli Lilly with wrongful death of 20 year old Cody Tadai who was prescribed Zyprexa®, a prescription drug used to treat schizophrenia and bipolar</description><guid>http://www.prlog.org/10395248-makarem-associates-files-wrongful-death-lawsuit-against-eli-lilly-for-its-drug-zyprexa.html</guid><category domain="http://www.zibb.com">Lilly, Eli, &amp; Co</category><pubDate>Fri, 30 Oct 2009 22:54:29 GMT</pubDate><source url="http://www.prlog.org" /></item><item><title>It's Not As Frightening As It First Appears (at Motley Fool)</title><link>http://www.fool.com/investing/general/2009/10/30/its-not-as-frightening-as-it-first-appears.aspx</link><description>(Nasdaq: MYL) earnings report wasn't pretty. Revenue fell by 24%, and the company lost $0.13 per share. Dig a little deeper, though, and you'll see the generic-drug maker is far from a copycat of its struggling branded-drug-making counterparts.</description><guid>http://www.fool.com/investing/general/2009/10/30/its-not-as-frightening-as-it-first-appears.aspx</guid><category domain="http://www.zibb.com">Lilly, Eli, &amp; Co</category><pubDate>Fri, 30 Oct 2009 18:56:05 GMT</pubDate><source url="http://www.fool.com" /></item><item><title>Eli Lilly to pay S. Carolina $45 million</title><link>http://www.upi.com/Business_News/2009/10/24/Eli-Lilly-to-pay-S-Carolina-45-million/UPI-53341256409719/</link><description>Eli Lilly has agreed to pay South Carolina a record $45 million to settle a dispute over the marketing of the anti-psychotic drug Zyprexa, officials say.</description><guid>http://www.upi.com/Business_News/2009/10/24/Eli-Lilly-to-pay-S-Carolina-45-million/UPI-53341256409719/</guid><category domain="http://www.zibb.com">Lilly, Eli, &amp; Co</category><pubDate>Sat, 24 Oct 2009 18:41:59 GMT</pubDate><source url="http://www.upi.com" /></item><item><title>Eli Lilly CEO banking on new drug pipeline</title><link>http://www.sfgate.com/cgi-bin/article.cgi?f=/n/a/2009/10/22/financial/f100554D36.DTL&amp;feed=rss.business</link><description>There are some life experiences few will ever have. And as the oldest of nine children and CEO of a Fortune 500 company, John Lechleiter has a couple under his belt. As Eli Lilly and Co.'s chairman and CEO, Lechleiter brings some of his childhood lessons to...</description><guid>http://www.sfgate.com/cgi-bin/article.cgi?f=/n/a/2009/10/22/financial/f100554D36.DTL&amp;feed=rss.business</guid><category domain="http://www.zibb.com">Lilly, Eli, &amp; Co</category><pubDate>Thu, 22 Oct 2009 18:33:33 GMT</pubDate><source url="http://www.sfgate.com" /></item><item><title>Novo Nordisk Diabetes Drug May Aid Weight Loss</title><link>http://www.cnbc.com//id/33438514</link><description>A new study shows that a diabetes treatment awaiting FDA approval may also work as a weightloss drug.</description><guid>http://www.cnbc.com//id/33438514</guid><category domain="http://www.zibb.com">Lilly, Eli, &amp; Co</category><pubDate>Thu, 22 Oct 2009 00:00:00 GMT</pubDate><source url="http://www.cnbc.com" /></item><item><title>Eli Lilly Q3: Beats Estimates, Raises Guidance</title><link>http://seekingalpha.com/article/167866-eli-lilly-q3-beats-estimates-raises-guidance?source=feed</link><description>Zacks.com submits: Wednesday, Eli Lilly  Co. (LLY) reported strong third</description><guid>http://seekingalpha.com/article/167866-eli-lilly-q3-beats-estimates-raises-guidance?source=feed</guid><category domain="http://www.zibb.com">Lilly, Eli, &amp; Co</category><pubDate>Wed, 21 Oct 2009 15:17:56 GMT</pubDate><source url="http://seekingalpha.com" /></item><item><title>Eli Lilly sells manufacturing plant, takes charge - Reuters</title><link>http://www.reuters.com/article/mergersNews/idUSN1423848820091014</link><description>* Financial terms of sale not disclosed * Lilly to take 23 cents/shr charge * Shares rise 1 percent (Updates with background) BOSTON, Oct 14 (Reuters) - Eli Lilly &amp; Co  said on Wednesday</description><guid>http://www.reuters.com/article/mergersNews/idUSN1423848820091014</guid><category domain="http://www.zibb.com">Lilly, Eli, &amp; Co</category><pubDate>Wed, 14 Oct 2009 13:35:23 GMT</pubDate><source url="http://www.reuters.com" /></item><item><title>SC AG McMaster accepted campaign cash from lawyers he hired</title><link>http://www.goupstate.com/article/20090924/articles/909249955</link><description>COLUMBIA — South Carolinas attorney general received campaign donations from private lawyers he hired to pursue a case against drug maker Eli Lilly &amp; Co., a potential violation of state law.Campaign finance</description><guid>http://www.goupstate.com/article/20090924/articles/909249955</guid><category domain="http://www.zibb.com">Lilly, Eli, &amp; Co</category><pubDate>Thu, 24 Sep 2009 21:11:00 GMT</pubDate><source url="http://www.goupstate.com" /></item><item><title>Eli Lilly says court upheld some Evista patents - Daily Report</title><link>http://www.dailyreportonline.com/Editorial/News/singleEdit.asp?individual_SQL=9/24/2009@35495&amp;rssFeed=free</link><description>INDIANAPOLIS (AP) — Eli Lilly &amp; Co. said Wednesday evening that a federal judge upheld some of the patents supporting its osteoporosis drug Evista. The court sided with Eli Lilly and against a challenge from Teva Pharmaceutical Industries Ltd.</description><guid>http://www.dailyreportonline.com/Editorial/News/singleEdit.asp?individual_SQL=9/24/2009@35495&amp;rssFeed=free</guid><category domain="http://www.zibb.com">Lilly, Eli, &amp; Co</category><pubDate>Thu, 24 Sep 2009 00:00:00 GMT</pubDate><source url="http://www.dailyreportonline.com" /></item><item><title>Eli Lilly to cut 5,500 jobs</title><link>http://www.themanufacturer.com/uk/content/9616/Eli_Lilly_to_cut_5%2C500_jobs</link><description>Global pharmaceutical firm Eli Lilly has announced plans to cut 13.6 per cent of its workforce in response to the loss of key patents and the lower drug prices as a result of US healthcare reforms.</description><guid>http://www.themanufacturer.com/uk/content/9616/Eli_Lilly_to_cut_5%2C500_jobs</guid><category domain="http://www.zibb.com">Lilly, Eli, &amp; Co</category><pubDate>Wed, 16 Sep 2009 15:00:13 GMT</pubDate><source url="http://www.themanufacturer.com" /></item><item><title>Eli Lilly to restructure, bet on drug portfolio</title><link>http://www.bloggingstocks.com/2009/09/15/eli-lilly-to-restructure-bet-on-drug-portfolio/</link><description>Filed under: Bad news, Industry, Marketing and</description><guid>http://www.bloggingstocks.com/2009/09/15/eli-lilly-to-restructure-bet-on-drug-portfolio/</guid><category domain="http://www.zibb.com">Lilly, Eli, &amp; Co</category><pubDate>Tue, 15 Sep 2009 15:40:00 GMT</pubDate><source url="http://www.bloggingstocks.com" /></item><item><title>Lilly to cut 14 pct of staff, trim $1B in costs</title><link>http://www.examiner.com/a-2217036~Lilly_to_cut_14_pct_of_staff__trim__1B_in_costs.html?cid=rss-Business</link><description>(AP Photo/Darron Cummings, File) FILE - In this Jan 25, 2006 file photo, The Eli Lilly and Company headquarters in pictured in Indianapolis. Drugmaker Eli Lilly &amp; Co. said Monday, Sept.</description><guid>http://www.examiner.com/a-2217036~Lilly_to_cut_14_pct_of_staff__trim__1B_in_costs.html?cid=rss-Business</guid><category domain="http://www.zibb.com">Lilly, Eli, &amp; Co</category><pubDate>Tue, 15 Sep 2009 02:08:09 GMT</pubDate><source url="http://www.examiner.com" /></item><item><title>Eli Lilly eyes 5,500 job cuts in bid to save $1bn a year</title><link>http://www.ft.com/cms/s/18962e90-a18e-11de-a88d-00144feabdc0,Authorised=false.html?_i_location=http%3A%2F%2Fwww.ft.com%2Fcms%2Fs%2F0%2F18962e90-a18e-11de-a88d-00144feabdc0.html%3Fftcamp%3Drss%26nclick_check%3D1&amp;_i_referer=&amp;ftcamp=rss&amp;nclick_check=1</link><description>The latest drugs, healthcare and pharmaceutical news from the Financial Times, with expert company and industry analysis on FT.com</description><guid>http://www.ft.com/cms/s/18962e90-a18e-11de-a88d-00144feabdc0,Authorised=false.html?_i_location=http%3A%2F%2Fwww.ft.com%2Fcms%2Fs%2F0%2F18962e90-a18e-11de-a88d-00144feabdc0.html%3Fftcamp%3Drss%26nclick_check%3D1&amp;_i_referer=&amp;ftcamp=rss&amp;nclick_check=1</guid><category domain="http://www.zibb.com">Lilly, Eli, &amp; Co</category><pubDate>Tue, 15 Sep 2009 02:00:00 GMT</pubDate><source url="http://www.ft.com" /></item></channel></rss>